NANDROLONE DECANOATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nandrolone Decanoate, and what generic alternatives are available?
Nandrolone Decanoate is a drug marketed by Abraxis Pharm, Am Regent, Epic Pharma Llc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in NANDROLONE DECANOATE is nandrolone decanoate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone decanoate profile page.
Summary for NANDROLONE DECANOATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Clinical Trials: | 10 |
Patent Applications: | 1,434 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NANDROLONE DECANOATE at DailyMed |
Recent Clinical Trials for NANDROLONE DECANOATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
King Edward Medical University | N/A |
Morten Tange Kristensen PT, PhD | Phase 2 |
University Hospital Ostrava | N/A |